Statistics
Publications
96
Citations
6.2K
H-Index
37
Active since
2005
Julie Kanter is an author at University of Alabama at Birmingham specializing in medicine, sickle cell disease, and sickle cell anemia.
Publications per year
2005–2025
96
96
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 876 citations · Full text
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text
A Phase 3 Trial of <scp>l</scp> -Glutamine in Sickle Cell Disease
Yutaka Niihara, Scott T. Miller, Julie Kanter et al. · New England Journal of Medicine · 2018 · 546 citations · Full text
Vivek Patel, Matthieu Mahévas, Soo Yong Lee et al. · Blood · 2012 · 344 citations · Full text
Medicine, Hematology, Immunology +7
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Rebecca Marsh, Carl E. Allen, Kenneth L. McClain et al. · Pediatric Blood & Cancer · 2012 · 311 citations · Full text
Medicine, Hematology, Pediatrics +10
1–5 of 96